Kisqali 400 MG daily dose 42S
Ended Awarded
- Contract number
- SPE2DB26FZSA1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $60,058
Award facts
- Contract value 100% obligated
- $60,058.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $60,058.09 delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Kisqali 400 mg daily dose tablets (42-count units), with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Kisqali (ribociclib) is a cyclin-dependent kinase inhibitor used in the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer, reflecting the Defense Logistics Agency's critical role in supplying specialized pharmaceutical products to military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a leading pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen maintains an extensive portfolio of federal contract awards across multiple therapeutic domains and serves as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting mechanism.
Quick answers
Who was awarded contract SPE2DB26FZSA1?
SPE2DB26FZSA1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FZSA1 worth?
The government has obligated $60,058 on SPE2DB26FZSA1.
Is contract SPE2DB26FZSA1 an order under another contract?
Yes. SPE2DB26FZSA1 is a delivery order under SPE2DB24D2010, an indefinite delivery contract.
Was contract SPE2DB26FZSA1 competed?
The extent of competition for SPE2DB26FZSA1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award